Aaron Diamond Aids Research is categorized under Medical Research in New York City, NY and active since 1989.
Aaron Diamond Aids Research was established in 1989, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 4483101 by the NAICS.
If you are seeking more information, feel free to contact David Ho, Chief Executive Officer at the company’s single location by writing to 455 1st Avenue, New York City, New York NY 10016 or by phoning (212) 725-2323. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Aaron Diamond Aids Research |
Contact Person: | David Ho, Chief Executive Officer |
Address: | 455 1st Avenue, New York City, New York 10016 |
Phone Number: | (212) 725-2323 |
Website Address: | adarc.org |
Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
Founded: | 1989 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Research |
SIC Code: | 8733 |
NAICS Code: | 4483101 |
Share This Business: |
Aaron Diamond Aids Research was started in 1989 to provide professional Medical Research under the SIC code 8733 and NAICS code 4483101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact David Ho, Chief Executive Officer for inquiries that concern Aaron Diamond Aids Research by calling the company number (212) 725-2323, as your correspondence is most welcome. Additionally, the physical location of the single location of Aaron Diamond Aids Research can be found at the coordinates 40.73928,-73.97689 as well as the street address 455 1st Avenue in New York City, New York 10016.
For its online presence, you may visit Aaron Diamond Aids Research’s website at adarc.org and engage with its social media outlets through on Twitter and on Facebook.